SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications - Neurodegenerative
An SI Board Since April 2002
Posts SubjectMarks Bans
448 38 0
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
373siliconinvestor.com is a good on-topic read. Regards, Dew p.s. genisi on iHub =DewDiligence_on_SI-9/22/2010
372Novartis gets approval for Gilenya pill for MS today. Interesting development vmopgcw-9/22/2010
371A small-molecule scaffold induces autophagy in primary neurons and protects agaitnsaf-9/12/2010
370Chuckle. true, but SF tends to work out easier for us on travel -- 3 days of homopgcw-8/31/2010
369Solution: spend Nov-Apr in Manitoba and spend May-Oct in southern Argentina :- )DewDiligence_on_SI-8/31/2010
368he**, i could have published that study. quite well known issue in the MS commumopgcw-8/31/2010
367That's why you ignore stunning phase 2 psoriasis results from Brazil :)rkrw-8/31/2010
366same as psoriasis patients given a trip to the sun :-)dalroi-8/31/2010
365Take the baseline in the warmer months and your primary endpoint measurement in rkrw18/31/2010
364WSJ: Studies Cast Doubt on New MS theory By THOMAS M. BURTON Research has ememopgcw-8/2/2010
363Good news for people with big heads....:) Big Head May Lessen Impact of Alzheimrkrw-7/15/2010
362Public release date: 12-Jul-2010 Contact: Paul Knekt, D.P.H. paul.knekt@thl.fi Ian@SI-7/12/2010
361NYT: From M.S. Patients, Outcry for Unproved Treatment By DENISE GRADY Publishemopgcw16/29/2010
360MS basic research <b>Two receptors explain MS?</b> the-scientist.cidos-6/17/2010
359Drug Makers Will Share Data From Failed Alzheimer's Trials By SHIRLEY S. Wtnsaf-6/12/2010
358Gilenia briefing docs and draft questions for the advisory panel: siliconinvestDewDiligence_on_SI-6/8/2010
357Researchers Question MoA of Bapineuzumab: siliconinvestor.comDewDiligence_on_SI-5/12/2010
356Here is the abs: ncbi.nlm.nih.gov Although Prof Anat Achiron is a highly respeidos-5/3/2010
355Thank you for explaining the context. I am always skeptical of reports from unsopgo-neil-5/2/2010
354The 20 subjects were NOT all randomly chosen, it was a retrospective genetic anaidos-5/2/2010
353MS New study claims ability to predict MS before onset... I am skeptical of thpgo-neil-5/2/2010
352MS - search for genetic, or epigenetic and environmental factors <b>Twinidos14/29/2010
351Dew Thanks regards John (It would be a Yahoo - if this stuff works)John McCarthy-4/21/2010
350John, the plasma-protein industry is a classic oligopoly; your post names all ofDewDiligence_on_SI-4/21/2010
349I am in over my head "language wise" but got curious as to how many cJohn McCarthy-4/21/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News